All skills
Skillintermediate

Common Methodological and Statistical Issues in Scientific Manuscripts

This document catalogs frequent issues encountered during peer review, organized by category. Use this as a reference to identify potential problems and provide constructive feedback.

Claude Code Knowledge Pack7/10/2026

Overview

Common Methodological and Statistical Issues in Scientific Manuscripts

This document catalogs frequent issues encountered during peer review, organized by category. Use this as a reference to identify potential problems and provide constructive feedback.

Statistical Issues

1. P-Value Misuse and Misinterpretation

Common Problems:

  • P-hacking (selective reporting of significant results)
  • Multiple testing without correction (familywise error rate inflation)
  • Interpreting non-significance as proof of no effect
  • Focusing exclusively on p-values without effect sizes
  • Dichotomizing continuous p-values at arbitrary thresholds (p=0.049 vs p=0.051)
  • Confusing statistical significance with biological/clinical significance

How to Identify:

  • Suspiciously high proportion of p-values just below 0.05
  • Many tests performed but no correction mentioned
  • Statements like "no difference was found" from non-significant results
  • No effect sizes or confidence intervals reported
  • Language suggesting p-values indicate strength of effect

What to Recommend:

  • Report effect sizes with confidence intervals
  • Apply appropriate multiple testing corrections (Bonferroni, FDR, Holm-Bonferroni)
  • Interpret non-significance cautiously (lack of evidence ≠ evidence of lack)
  • Pre-register analyses to avoid p-hacking
  • Consider equivalence testing for "no difference" claims

2. Inappropriate Statistical Tests

Common Problems:

  • Using parametric tests when assumptions are violated (non-normal data, unequal variances)
  • Analyzing paired data with unpaired tests
  • Using t-tests for multiple groups instead of ANOVA with post-hoc tests
  • Treating ordinal data as continuous
  • Ignoring repeated measures structure
  • Using correlation when regression is more appropriate

How to Identify:

  • No mention of assumption checking
  • Small sample sizes with parametric tests
  • Multiple pairwise t-tests instead of ANOVA
  • Likert scales analyzed with t-tests
  • Time-series data analyzed without accounting for repeated measures

What to Recommend:

  • Check assumptions explicitly (normality tests, Q-Q plots)
  • Use non-parametric alternatives when appropriate
  • Apply proper corrections for multiple comparisons after ANOVA
  • Use mixed-effects models for repeated measures
  • Consider ordinal regression for ordinal outcomes

3. Sample Size and Power Issues

Common Problems:

  • No sample size justification or power calculation
  • Underpowered studies claiming "no effect"
  • Post-hoc power calculations (which are uninformative)
  • Stopping rules not pre-specified
  • Unequal group sizes without justification

How to Identify:

  • Small sample sizes (n<30 per group for typical designs)
  • No mention of power analysis in methods
  • Statements about post-hoc power
  • Wide confidence intervals suggesting imprecision
  • Claims of "no effect" with large p-values and small n

What to Recommend:

  • Conduct a priori power analysis based on expected effect size
  • Report achieved power or precision (confidence interval width)
  • Acknowledge when studies are underpowered
  • Consider effect sizes and confidence intervals for interpretation
  • Pre-register sample size and stopping rules

4. Missing Data Problems

Common Problems:

  • Complete case analysis without justification (listwise deletion)
  • Not reporting extent or pattern of missingness
  • Assuming data are missing completely at random (MCAR) without testing
  • Inappropriate imputation methods
  • Not performing sensitivity analyses

How to Identify:

  • Different n values across analyses without explanation
  • No discussion of missing data
  • Participants "excluded from analysis"
  • Simple mean imputation used
  • No sensitivity analyses comparing complete vs. imputed data

What to Recommend:

  • Report extent and patterns of missingness
  • Test MCAR assumption (Little's test)
  • Use appropriate methods (multiple imputation, maximum likelihood)
  • Perform sensitivity analyses
  • Consider intention-to-treat analysis for trials

5. Circular Analysis and Double-Dipping

Common Problems:

  • Using the same data for selection and inference
  • Defining ROIs based on contrast then testing that contrast in same ROI
  • Selecting outliers then testing for differences
  • Post-hoc subgroup analyses presented as planned
  • HARKing (Hypothesizing After Results are Known)

How to Identify:

  • ROIs or features selected based on results
  • Unexpected subgroup analyses
  • Post-hoc analyses not clearly labeled as exploratory
  • No data-independent validation
  • Introduction that perfectly predicts findings

What to Recommend:

  • Use independent datasets for selection and testing
  • Pre-register analyses and hypotheses
  • Clearly distinguish confirmatory vs. exploratory analyses
  • Use cross-validation or hold-out datasets
  • Correct for selection bias

6. Pseudoreplication

Common Problems:

  • Technical replicates treated as biological replicates
  • Multiple measurements from same subject treated as independent
  • Clustered data analyzed without accounting for clustering
  • Non-independence in spatial or temporal data

How to Identify:

  • n defined as number of measurements rather than biological units
  • Multiple cells from same animal counted as independent
  • Repeated measures not acknowledged
  • No mention of random effects or clustering

What to Recommend:

  • Define n as biological replicates (animals, patients, independent samples)
  • Use mixed-effects models for nested or clustered data
  • Account for repeated measures explicitly
  • Average technical replicates before analysis
  • Report both technical and biological replication

Experimental Design Issues

7. Lack of Appropriate Controls

Common Problems:

  • Missing negative controls
  • Missing positive controls for validation
  • No vehicle controls for drug studies
  • No time-matched controls for longitudinal studies
  • No batch controls

How to Identify:

  • Methods section lists only experimental groups
  • No mention of controls in figures
  • Unclear baseline or reference condition
  • Cross-batch comparisons without controls

What to Recommend:

  • Include negative controls to assess specificity
  • Include positive controls to validate methods
  • Use vehicle controls matched to experimental treatment
  • Include sham surgery controls for surgical interventions
  • Include batch controls for cross-batch comparisons

8. Confounding Variables

Common Problems:

  • Systematic differences between groups besides intervention
  • Batch effects not controlled or corrected
  • Order effects in sequential experiments
  • Time-of-day effects not controlled
  • Experimenter effects not blinded

How to Identify:

  • Groups differ in multiple characteristics
  • Samples processed in different batches by group
  • No randomization of sample order
  • No mention of blinding
  • Baseline characteristics differ between groups

What to Recommend:

  • Randomize experimental units to conditions
  • Block on known confounders
  • Randomize sample processing order
  • Use blinding to minimize bias
  • Perform batch correction if needed
  • Report and adjust for baseline differences

9. Insufficient Replication

Common Problems:

  • Single experiment without replication
  • Technical replicates mistaken for biological replication
  • Small n justified by "typical for the field"
  • No independent validation of key findings
  • Cherry-picking representative examples

How to Identify:

  • Methods state "experiment performed once"
  • n=3 with no justification
  • "Representative image shown"
  • Key claims based on single experiment
  • No validation in independent dataset

What to Recommend:

  • Perform independent biological replicates (typically ≥3)
  • Validate key findings in independent cohorts
  • Report all replicates, not just representative examples
  • Conduct power analysis to justify sample size
  • Show individual data points, not just summary statistics

Reproducibility Issues

10. Insufficient Methodological Detail

Common Problems:

  • Methods not described in sufficient detail for replication
  • Key reagents not specified (vendor, catalog number)
  • Software versions and parameters not reported
  • Antibodies not validated
  • Cell line authentication not verified

How to Identify:

  • Vague descriptions ("standard protocols were used")
  • No information on reagent sources
  • Generic software mentioned without versions
  • No antibody validation information
  • Cell lines not authenticated

What to Recommend:

  • Provide detailed protocols or cite specific protocols
  • Include reagent vendors, catalog numbers, lot numbers
  • Report software versions and all parameters
  • Include antibody validation (Western blot, specificity tests)
  • Report cell line authentication method (STR profiling)
  • Make protocols available (protocols.io, supplementary materials)

11. Data and Code Availability

Common Problems:

  • No data availability statement
  • "Data available upon request" (often unfulfilled)
  • No code provided for computational analyses
  • Custom software not made available
  • No clear documentation

How to Identify:

  • Missing data availability statement
  • No repository accession numbers
  • Computational methods with no code
  • Custom pipelines without access
  • No README or documentation

What to Recommend:

  • Deposit raw data in appropriate repositories (GEO, SRA, Dryad, Zenodo)
  • Share analysis code on GitHub or similar
  • Provide clear documentation and README files
  • Include requirements.txt or environment files
  • Make custom software available with installation instructions
  • Use DOIs for permanent data citation

12. Lack of Method Validation

Common Problems:

  • New methods not compared to gold standard
  • Assays not validated for specificity, sensitivity, linearity
  • No spike-in controls
  • Cross-reactivity not tested
  • Detection limits not established

How to Identify:

  • Novel assays presented without validation
  • No comparison to existing methods
  • No positive/negative controls shown
  • Claims of specificity without evidence
  • No standard curves or controls

What to Recommend:

  • Validate new methods against established approaches
  • Show specificity (knockdown/knockout controls)
  • Demonstrate linearity and dynamic range
  • Include positive and negative controls
  • Report limits of detection and quantification
  • Show reproducibility across replicates and operators

Interpretation Issues

13. Overstatement of Results

Common Problems:

  • Causal language for correlational data
  • Mechanistic claims without mechanistic evidence
  • Extrapolating beyond data (species, conditions, populations)
  • Claiming "first to show" without thorough literature review
  • Overgeneralizing from limited samples

How to Identify:

  • "X causes Y" from observational data
  • Mechanism proposed without direct testing
  • Mouse data presented as relevant to humans without caveats
  • Claims of novelty with missing citations
  • Broad claims from narrow samples

What to Recommend:

  • Use appropriate language ("associated with" vs. "caused by")
  • Distinguish correlation from causation
  • Acknowledge limitations of model systems
  • Provide thorough literature context
  • Be specific about generalizability
  • Propose mechanisms as hypotheses, not conclusions

14. Cherry-Picking and Selective Reporting

Common Problems:

  • Reporting only significant results
  • Showing "representative" images that may not be typical
  • Excluding outliers without justification
  • Not reporting negative or contradictory findings
  • Switching between different statistical approaches

How to Identify:

  • All reported results are significant
  • "Representative of 3 experiments" with no quantification
  • Data exclusions mentioned in results but not methods
  • Supplementary data contradicts main findings
  • Multiple analysis approaches with only one reported

What to Recommend:

  • Report all planned analyses regardless of outcome
  • Quantify and show variability across replicates
  • Pre-specify outlier exclusion criteria
  • Include negative results
  • Pre-register analysis plan
  • Report effect sizes and confidence intervals for all comparisons

15. Ignoring Alternative Explanations

Common Problems:

  • Preferred explanation presented without considering alternatives
  • Contradictory evidence dismissed without discussion
  • Off-target effects not considered
  • Confounding variables not acknowledged
  • Limitations section minimal or absent

How to Identify:

  • Single interpretation presented as fact
  • Prior contradictory findings not cited or discussed
  • No consideration of alternative mechanisms
  • No discussion of limitations
  • Specificity assumed without controls

What to Recommend:

  • Discuss alternative explanations
  • Address contradictory findings from literature
  • Include appropriate specificity controls
  • Acknowledge and discuss limitations thoroughly
  • Consider and test alternative hypotheses

Figure and Data Presentation Issues

16. Inappropriate Data Visualization

Common Problems:

  • Bar graphs for continuous data (hiding distributions)
  • No error bars or error bars not defined
  • Truncated y-axes exaggerating differences
  • Dual y-axes creating misleading comparisons
  • Too many significant figures
  • Colors not colorblind-friendly

How to Identify:

  • Bar graphs with few data points
  • Unclear what error bars represent (SD, SEM, CI?)
  • Y-axis doesn't start at zero for ratio/percentage data
  • Left and right y-axes with different scales
  • Values reported to excessive precision (p=0.04562)
  • Red-green color schemes

What to Recommend:

  • Show individual data points with scatter/box/violin plots
  • Always define error bars (SD, SEM, 95% CI)
  • Start y-axis at zero or indicate breaks clearly
  • Avoid dual y-axes; use separate panels instead
  • Report appropriate significant figures
  • Use colorblind-friendly palettes (viridis, colorbrewer)
  • Include sample sizes in figure legends

17. Image Manipulation Concerns

Common Problems:

  • Excessive contrast/brightness adjustment
  • Spliced gels or images without indication
  • Duplicated images or panels
  • Uneven background in Western blots
  • Selective cropping
  • Over-processed microscopy images

How to Identify:

  • Suspicious patterns or discontinuities
  • Very high contrast with no background
  • Similar features in different panels
  • Straight lines suggesting splicing
  • Inconsistent backgrounds
  • Loss of detail suggesting over-processing

What to Recommend:

  • Apply adjustments uniformly across images
  • Indicate spliced gels with dividing lines
  • Show full, uncropped images in supplementary materials
  • Provide original images if requested
  • Follow journal image integrity policies
  • Use appropriate image analysis tools

Study Design Issues

18. Poorly Defined Hypotheses and Outcomes

Common Problems:

  • No clear hypothesis stated
  • Primary outcome not specified
  • Multiple outcomes without correction
  • Outcomes changed after data col